The biological activity of FGF21-WT, FGF21–3PM, and FGF21–4PM was further determined by cell proliferation assay using Hep G2 hepatocellular carcinoma cells and NIH 3T3 fibroblasts. Here, FGF21 is linked to hepatocellular carcinoma.